prescribing – Page 2 – SASHA: South Australian Sexual Health Awareness

U.S. FDA Approves Evofem Biosciences’ Phexxi™, the First Non-Hormonal Prescription Gel for the Prevention of Pregnancy

1 Min Read

U

Evofem Biosciences via PRNewswire, May 22nd 2020 Evofem Biosciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and potassium bitartrate) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. Phexxi is the first non-hormonal, on-demand...

Read on Read later

Nurse Practitioner (s100) Prescribing Change

By J Pope

In Hepatitis

2 Min Read

N

Hepatitis Australia, 3 April 2020 Hepatitis Australia warmly welcomes recent changes to the Pharmaceutical Benefits Scheme (PBS) allowing authorised Nurse Practitioners to prescribe hepatitis B and hepatitis C medicines under the Highly Specialised Drugs (s100) Program. Both hepatitis B and hepatitis C are under-treated and without improvement in a range of areas Australia risks falling short of...

Read on Read later

Information about TRUVADA and ATRIPLA delisting

By J Pope

In Gay Lesbian & Bisexual Health, HIV, LGBTIQ+ issues

1 Min Read

I

Australian Federation of AIDS Organisations (AFAO), March 30th 2020 From 1 April 2020 Truvada for HIV treatment and for pre-exposure prophylaxis (PrEP) will no longer be available through the Pharmaceutical Benefits Scheme (PBS). There are alternatives to Truvada for PrEP in Australia. Community members eligible for PrEP can access generic versions of Truvada supplied by Apotex, Mylan and Lupin...

Read on Read later

Emergency contraception awareness in an at‐risk population

By J Pope

In Contraception, Young people

2 Min Read

E

Hope, D. L., Hattingh, L. and King, M. A. (2019) J Pharm Pract Res. doi:10.1002/jppr.1554 Background Consumer awareness of emergency contraception is generally poor. School leavers (schoolies) engage in risky behaviours, including casual sex and alcohol and drug consumption. Aim The aim of this study was to explore the awareness of an at‐risk population of schoolies regarding the use and...

Read on Read later

International consensus on testosterone treatment for women

By J Pope

In Reproductive health, Sexual dysfunction

1 Min Read

I

Jean Hailes, 2 September 2019 The first Global Position Statement on the use of testosterone in the treatment of women, led by the International Menopause Society (IMS), was published in four leading international medical journals today. The statement has been authored by a diverse team of leading experts based around the world and has been endorsed by internationally-esteemed medical societies...

Read on Read later

It’s time to lift the restrictions on medical abortion in Australia – Professor Caroline de Costa

By J Pope

In Crime and law, Pregnancy choices, Reproductive health

1 Min Read

I

The Conversation, April 1, 2019 6.13am AEDT Over the past thirteen years, many Australian women have used the drug mifepristone (RU486) to bring about a medical abortion. Rather than undergoing a surgical abortion in a clinic or hospital operating theatre, a medical abortion is induced by taking drugs prescribed by a doctor. But while mifepristone has been available in Australia since 2006, only...

Read on Read later

Tagprescribing